3:31 PM
May 12, 2017
 |  BC Extra  |  Financial News

Ziopharm raises $50M in follow-on

Cancer company Ziopharm Oncology Inc. (NASDAQ:ZIOP) raised $50 million through the sale of 9.7 million shares at $5.15 in a follow-on underwritten by Guggenheim. The price is...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >